Nephrology With Joel Topf, MD

Nephrology

Dr. Topf is an assistant clinical professor of medicine at Oakland University William Beaumont School of Medicine, creator and host of the Freely Filtered and Channel Your Enthusiasm podcasts, creator of the Precious Bodily Fluids blog, and co-creator of NephMadness and NephJC.


2025 Begins With Major Health Headlines

Hello readers,

Welcome to 2025. Looking at the big health headlines coming from the NIH, it’s going to be a rough year. So, to maintain your mental health, let’s look elsewhere for the monthly newsletter.

KDIGO published its first guidelines on autosomal dominant polycystic kidney disease. Set aside some time to go through them; the executive summary alone is 20 pages.

Nature Medicine published an interesting trial that mined the VA electronic health record to look for the effects, both good and bad, of GLP-1 RA. The results are super interesting, with strong signals revealing decreased sepsis, pneumonia, and schizophrenia. The negative signals were for musculoskeletal complaints and, interestingly, kidney stones. I have included links to the manuscript, as well as two summaries by Perry Wilson: one on Medscape and the other a Tweetorial on Bluesky.

Speaking of Bluesky and Nature Medicine, Nature did an unscientific poll of their readers and found that 70%(!?) of their audience has moved to Bluesky.

And lastly, as January rolls into February, we’re getting closer to #NephMadness. This year’s contest drops on March 1st. AJKDblog continues the rollout with the annual Meet the Gamemakers post. Link below.

Stay warm, readers.
Spring will soon be here.

Joel Topf, MD


Articles
  • Mashup Score: 0

    Read the full article here

    Tweet Tweets with this article
    • As January closes we are getting closer to the opening of NephMadness 2025. AJKD revealed the editorial team, the game makers. The team has three new faces: Ana Catalina, Dia Waguespack, and Krithika Mohan.

  • Mashup Score: 0
    Tweet Tweets with this article
    • Cool study that leverages the VA EHR to look for all of the effects, good and bad, of GLP1ra. Lots of good, news, little bad, though some of it unexpected.

      Pros: Shock, aspiration pneumonia, hep[atic failure, respiratory failure, cardiac arrest, bulemia, schizophrenia, hemorrhagic stroke, pulmonary hypertension and on and on and on.

      Cons, besides the expected GI side effects there were increased risk musculoskeletal complaints, kidney stones, and headache.

  • Mashup Score: 0

    Read the full article here

    Tweet Tweets with this article
    • If you don't have access to Nature Medicine, Perry Wilson does an amazing job reviewing the study for MedScape. 

  • Mashup Score: 0
    GLP1ra Study Tweetorial - 3 month(s) ago

    Read the full article here

    Tweet Tweets with this article
    • And if you have the attention span of 55 year old twitter addicted nephrologist, can I suggest, Perry Wilson's tweetorial on the study at Bluesky?